These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 12680862)

  • 1. Systemic reactions to immunotherapy: influence of composition and manufacturer.
    Gastaminza G; Algorta J; Audicana M; Etxenagusia M; Fernández E; Muñoz D
    Clin Exp Allergy; 2003 Apr; 33(4):470-4. PubMed ID: 12680862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
    Asero R
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy units: a follow-up study.
    Machín IS; Robaina JCG ; Bonnet C; de Blas C; Fernández-Caldas E; Triviño MS; de la Morin FT
    J Investig Allergol Clin Immunol; 2001; 11(3):167-71. PubMed ID: 11831448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of inhalant allergen immunotherapy with mass units-standardized extracts.
    Nettis E; Giordano D; Pannofino A; Ferrannini A; Tursi A
    Clin Exp Allergy; 2002 Dec; 32(12):1745-9. PubMed ID: 12653166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Possible relationship between systemic side effects and sensitization to rPar j 2 in allergic patients submitted to an ultra-rush (20 min) sublingual immunotherapy and selected by component resolved diagnosis.
    Rossi RE; Monasterolo G; Coco G; Operti D
    Int Arch Allergy Immunol; 2005 Oct; 138(2):105-10. PubMed ID: 16174987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts.
    Casanovas M; Martín R; Jiménez C; Caballero R; Fernández-Caldas E
    Int Arch Allergy Immunol; 2006; 139(2):153-8. PubMed ID: 16374026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety of allergen immunotherapy (IT) in Turkey.
    Dursun AB; Sin BA; Oner F; Misirligil Z
    J Investig Allergol Clin Immunol; 2006; 16(2):123-8. PubMed ID: 16689186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.
    Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline serum tryptase levels and adverse reactions to injection specific immunotherapy with airborne allergens: is there a relationship?
    Asero R; Farioli L; Pastorello EA
    Int Arch Allergy Immunol; 2012; 158(3):276-80. PubMed ID: 22398453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse reactions to immunotherapy in pediatric patients].
    Avila Castañón L; Lerma-Ortiz L; Velázquez Armenta Y; del Rio Navarro BE; Sienra Monge JJ
    Rev Alerg Mex; 2003; 50(5):182-6. PubMed ID: 14631589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.
    Calderón MA; Vidal C; Rodríguez Del Río P; Just J; Pfaar O; Tabar AI; Sánchez-Machín I; Bubel P; Borja J; Eberle P; Reiber R; Bouvier M; Lepelliez A; Klimek L; Demoly P;
    Allergy; 2017 Mar; 72(3):462-472. PubMed ID: 27718250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accelerated immunotherapy schedules: review of efficacy and safety.
    Cox L
    Ann Allergy Asthma Immunol; 2006 Aug; 97(2):126-37; quiz 137-40, 202. PubMed ID: 16937741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Local and systemic reactions to subcutaneous allergen immunotherapy: Ten years' experience in a pediatric clinic.
    Nacaroglu HT; Erdem SB; Sumer O; Karaman S; Unsal Karkıner CS; Asilsoy S; Gunay I; Can D
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):349-53. PubMed ID: 26905639
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The rate of systemic reactions to immunotherapy injections is the same whether or not the dose is reduced after a local reaction.
    Kelso JM
    Ann Allergy Asthma Immunol; 2004 Feb; 92(2):225-7. PubMed ID: 14989390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for adverse systemic reactions occurring during immunotherapy with standardized Dermatophagoides farinae extracts.
    Ohashi Y; Nakai Y; Tanaka A; Kakinoki Y; Washio Y; Ohno Y; Yamada K; Nasako Y
    Acta Otolaryngol Suppl; 1998; 538():113-7. PubMed ID: 9879410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immediate adverse reactions to immunotherapy.
    Can D; Demir E; Tanaç R; Gülen F; Yenigün A
    J Investig Allergol Clin Immunol; 2003; 13(3):177-80. PubMed ID: 14635467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adverse reactions to venom immunotherapy.
    Ramirez DA; Londono S; Evans R
    Ann Allergy; 1981 Dec; 47(6):435-9. PubMed ID: 7325415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of allergen-specific immunotherapy. Relation between dosage regimen, allergen extract, disease and systemic side-effects during induction treatment.
    Mellerup MT; Hahn GW; Poulsen LK; Malling H
    Clin Exp Allergy; 2000 Oct; 30(10):1423-9. PubMed ID: 10998019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics and dynamic evaluation of specific immunotherapy.
    Pereira C; Botelho F; Tavares B; Lourenço C; Baeta C; Palma-Carlos AG; Lima J; Chieira C
    Eur Ann Allergy Clin Immunol; 2004 Dec; 36(10):375-86. PubMed ID: 15662966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.